KELSEY PUSKAR: Open Payments
NPI 1104465467 · NEW WILMINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,476 in 199 payments from 24 companies in 2025. Trend: 2023 $4,125 · 2024 $2,711 · 2025 $3,476
Food & beverage: $3,466Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $369 |
| GlaxoSmithKline, LLC. | 20 | $366 |
| Amgen Inc. | 21 | $346 |
| Novo Nordisk Inc | 15 | $278 |
| Lilly USA, LLC | 20 | $274 |
| Lundbeck LLC | 14 | $272 |
| AstraZeneca Pharmaceuticals LP | 8 | $252 |
| Otsuka America Pharmaceutical, Inc. | 15 | $246 |
| Amphastar Pharmaceuticals, Inc. | 11 | $217 |
| PFIZER INC. | 10 | $198 |
Products named: REXULTI, TRELEGY ELLIPTA, JARDIANCE, OTEZLA, MOUNJARO, FARXIGA, ELIQUIS, Ozempic.
Industry payments across PA — which companies pay providers there.
